GLP-1 for Obesity: Management Quiz

Froggy Jumps

Jugadas 0

Crear copia

Sobre esta actividad

GLP-1 obesity quiz

Creada por

Dr. May Elassal

Egipto

Descarga la versión para jugar en papel

Top 10 resultados

Todavía no hay resultados para este juego. ¡Sé el primero en aparecer en el ranking! Inicia sesión para identificarte.

Crea tu propio juego gratis desde nuestro creador de juegos

Compite contra tus amigos para ver quien consigue la mejor puntuación en esta actividad

Crear reto

Quiz de Culpa mía película

Yamila Chavez

Argentina

(179)

Demuestra cuánto sabes sobre la película Culpa mía con este divertido quiz.
OPEN UP 6 UNIT 1 VOCABULARY

karen blixen

España

(102)

Repasamos el vocabulario de la unidad
Sabiduría animal

Educaplay Educational Resources

España

(15514)

Conviértete en un genio del Reino Animal
Salva a la Ranita

Melanie Rodriguez

Estados Unidos

(345)

Contesta las siguientes multiplicaciones correctamente para salvar a la ranita y evitar que caiga al agua, mucha suerte!
El valle de los lobos

Marcos Signes

España

(111)

20 preguntas de este maravilloso libro

		%
	Anónimo	%
		%
		%

Imprime tu juego

GLP-1 for Obesity: Management Quiz


Froggy Jumps GLP-1 for Obesity: Management QuizVersión en línea GLP-1 obesity quiz por Dr. May Elassal 1 Which GLP-1 receptor agonist is approved specifically for chronic weight management at higher doses than diabetes care? a Liraglutide (Saxenda) b Semaglutide (Wegovy) c Dulaglutide (Trulicity) 2 What is the primary mechanism by which GLP-1 receptor agonists aid weight loss? a Increase basal metabolic rate b Block fat absorption in the intestines c Decrease appetite via hypothalamic pathways 3 Which patient population is a key consideration before starting GLP-1 therapy for obesity? a Recent antibiotic use b A history of medullary thyroid carcinoma or MEN2 syndrome c Controlled hypertension 4 Common adverse effects of GLP-1 receptor agonists include which of the following? a Nausea and vomiting b Hyperglycemia c Hypertension 5 What is a typical starting approach for dosing liraglutide when used for obesity? a Begin at full diabetes dose b Use once daily without titration c Start low and titrate up gradually 6 Which GLP-1 agent is administered weekly for obesity management? a Semaglutide (subcutaneous weekly) b Exenatide (daily) c Liraglutide (daily) 7 GLP-1 therapy for obesity is often combined with what non-pharmacologic strategy? a Immediate surgical intervention b Lifestyle modification including diet and exercise c Antibiotic therapy 8 Which monitoring parameter is important when initiating GLP-1 therapy for obesity? a Blood glucose only at baseline b Renal ultrasound every visit c Monitoring for pancreatitis symptoms 9 Which of the following statements is true about GLP-1 therapy and type 2 diabetes? a GLP-1 agents can aid weight loss in non-diabetic patients b They are ineffective for weight loss in all patients c They cure obesity 10 Which contraindication would prompt reconsideration of GLP-1 obesity therapy? a Controlled cholesterol b A history of pancreatitis c Mild iron deficiency

Puedes integrar el juego en un LMS compatible con LTI 1.1 o LTI 1.3 como Canvas, Moodle, o Blackboard. De esta manera podrás guardar las puntuaciones automáticamente en el libro de calificaciones de esa plataforma.

GLP-1 for Obesity: Management Quiz

Froggy Jumps

Sobre esta actividad

Creada por

Descarga la versión para jugar en papel

Top juegos

Froggy Jumps

Quiz de Culpa mía película

Froggy Jumps

OPEN UP 6 UNIT 1 VOCABULARY

Froggy Jumps

Sabiduría animal

Froggy Jumps

Salva a la Ranita

Froggy Jumps

El valle de los lobos

Froggy Jumps

GLP-1 for Obesity: Management QuizVersión en línea

por Dr. May Elassal

Which GLP-1 receptor agonist is approved specifically for chronic weight management at higher doses than diabetes care?

What is the primary mechanism by which GLP-1 receptor agonists aid weight loss?

Which patient population is a key consideration before starting GLP-1 therapy for obesity?

Common adverse effects of GLP-1 receptor agonists include which of the following?

What is a typical starting approach for dosing liraglutide when used for obesity?

Which GLP-1 agent is administered weekly for obesity management?

GLP-1 therapy for obesity is often combined with what non-pharmacologic strategy?

Which monitoring parameter is important when initiating GLP-1 therapy for obesity?

Which of the following statements is true about GLP-1 therapy and type 2 diabetes?

Which contraindication would prompt reconsideration of GLP-1 obesity therapy?